As of 4:06pm ET
| -0.01 / -0.02%|
The 30 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 50.51, with a high estimate of 57.97 and a low estimate of 35.92. The median estimate represents a +13.48% increase from the last price of 44.51.
The current consensus among 32 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.